SBSG Stock Overview

Designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. More details

SBSG fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	1/6
Financial Health	4/6
Dividends	2/6

Rewards

Trading at 50.8% below our estimate of its fair value

Earnings are forecast to grow 25.12% per year

Analysts in good agreement that stock price will rise by 66%

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Stratec SE Competitors

Jiangsu Canopus Wisdom Medical TechnologyLtd

SZSE:301290

CN¥2.4b

Nanjing Medlander Medical TechnologyLtd

SHSE:688273

CN¥2.8b

Semler Scientific

NasdaqCM:SMLR

US$347.4m

Zhejiang Canaan Technology

SZSE:300412

CN¥2.7b

Price History & Performance

Summary of share price highs, lows and changes for Stratec
Historical stock prices
Current Share Price	€24.80
52 Week High	€29.40
52 Week Low	€24.10
Beta	0.35
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-13.74%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	SBSG	AT Medical Equipment	AT Market
7D	-4.1%	-2.9%	-1.6%
1Y	n/a	2.9%	12.6%

Return vs Industry: Insufficient data to determine how SBSG performed against the Austrian Medical Equipment industry.

Return vs Market: Insufficient data to determine how SBSG performed against the Austrian Market.

Price Volatility

Is SBSG's price volatile compared to industry and market?
SBSG volatility
SBSG Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	4.4%
10% most volatile stocks in AT Market	8.0%
10% least volatile stocks in AT Market	2.4%

Stable Share Price: SBSG's share price has been volatile over the past 3 months compared to the Austrian market.

Volatility Over Time: Insufficient data to determine SBSG's volatility change over the past year.

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

About the Company

Founded	Employees	CEO	Website
2018	1,462	Marcus Wolfinger	www.stratec.com

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.

Stratec SE Fundamentals Summary

How do Stratec's earnings and revenue compare to its market cap?
SBSG fundamental statistics
Market cap	€300.25m
Earnings (TTM)	€10.01m
Revenue (TTM)	€250.54m

30.0x

P/E Ratio

1.2x

P/S Ratio

Is SBSG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SBSG income statement (TTM)
Revenue	€250.54m
Cost of Revenue	€182.78m
Gross Profit	€67.75m
Other Expenses	€57.74m
Earnings	€10.01m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 29, 2025

Earnings per share (EPS)	0.82
Gross Margin	27.04%
Net Profit Margin	4.00%
Debt/Equity Ratio	67.0%

How did SBSG perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

67%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/01 01:51
End of Day Share Price	2025/04/01 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stratec SE is covered by 19 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Volker Braun	Bankhaus Lampe KG
Odysseas Manesiotis	Berenberg
Scott Bardo	Berenberg